Would you enjoy helping to move the pharmaceutical industry forward by facilitating the communication of scientific data and the sharing of knowledge among medical experts all over the world? Does interacting with leading Global Medical Doctors and Scientists on new innovative portfolio interest you? If yes join us on an exciting journey where we will establish our presence in NASH and build a pipeline that goes beyond the treatment of metabolic diseases.
In Other Serious Chronic Diseases (OSCD), we aim to create a strong presence by building a competitive pipeline and scientific leadership. Our focus will be on non-alcoholic steatohepatitis (NASH) and New Therapy Areas such as chronic kidney disease (CKD), cardiovascular (CVD), inflammation and Alzheimer’s disease.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs over 43,000 people in80 countries, and markets its products in more than 170 countries.
The position
We are looking for a Medical Manager, NASH to join us. You will be part of the Novo Nordisk South Korea Clinical, Medical, Regulatory Affairs team, partnering with other departments todevelop and execute NASH medical affairs strategy, build advocacy, build competencies and drive the setup of NASH New therapeutic Area. You will report to the Senior Director, Clinical, Medical & Regulatory (CMR), Korea. As a Medical Manager, you are responsible for the planning and execution of the local medical strategy for development of the NASH therapy area. You will be instrumental in the identification and segmentation of KOLs relevant to the NASH therapy area and develop engagement plans, including obtaining expert advice to guide local decisions and strategy. This position requires a relatively moderate to high level (around 20-30%) of travelling within the country and abroad.
You will draft and adapt a global publication plan with regards to the local needs and regulations. You will also liaise with relevant professional associations, including congress activities in support of Novo Nordisk presence in the NASH area. Providing guidance and training internally to support capability building in (affiliate) as well as giving support to clinical operations in the execution of clinical trials in NASH, in geographies where medical resources to support NASH studies are not available are also key responsibilities. You will seek opportunities and advice to obtain understanding of the market and patient pathways within NASH in support of internal medical and commercial business decisions and scientific development of NASH area. Close collaboration with medical and commercial colleagues in obesity to ensure strategic alignment and synergy of NASH within obesity is key to success.
About the department
Novo Nordisk Korea has established a strong foothold as a market leader which has offered best solutions for people with diabetes, obesity, haemophilia and growth hormones disorder for more than 30 years. The affiliate has been delivering double digit sales growth year-on year. Our sales growth stands-out in the market and within Novo Nordisk. The affiliate is ranked among the top 15 within Novo Nordisk in term of total revenue generated. With our Ambition 2021 (“Strive for Quality of Life for Everyone”), we have strived to accelerate business growth, optimize organizational excellence, and attract and retain the best talents. It is an exciting time to join Novo Nordisk and achieve our strategic aspirations to establish global presence in the treatment in NASH. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future.